Oct 7, 2021 05:41PM
Sep 27, 2021 08:30AM
Sep 27, 2021 08:30AM
Sep 27, 2021 08:30AM
Aug 9, 2021 04:05PM
Aug 9, 2021 04:05PM
Jul 6, 2021 05:19PM Stifel Upgrades ChemoCentryx (CCXI) to Buy on Amendment To Avacopan NDA
Jul 6, 2021 04:54PM
Jul 6, 2021 08:30AM
Jul 6, 2021 08:30AM
Jul 6, 2021 08:30AM
Jun 8, 2021 08:30AM
Jun 8, 2021 08:30AM
May 7, 2021 09:36AM ChemoCentryx (CCXI) Crashes 55% on Mixed AdComm Results, Gets Downgraded at Five Firms
May 7, 2021 07:38AM
May 7, 2021 06:48AM
May 7, 2021 05:12AM
May 6, 2021 11:37PM
May 6, 2021 11:37PM
Apr 29, 2021 04:05PM
Apr 29, 2021 04:05PM ChemoCentryx Reports First Quarter 2021 Financial Results and Recent Highlights
Mar 1, 2021 04:05PM
Mar 1, 2021 04:05PM
Feb 24, 2021 08:32AM
Feb 24, 2021 08:30AM
Feb 24, 2021 08:30AM
Feb 17, 2021 05:01PM
Feb 17, 2021 05:00PM ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
Feb 17, 2021 05:00PM
Nov 9, 2020 04:05PM
Nov 9, 2020 04:05PM
Nov 6, 2020 08:30AM
Nov 6, 2020 08:30AM
Sep 17, 2020 08:33AM
Sep 17, 2020 08:30AM ChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated Vasculitis
Sep 17, 2020 08:30AM
Sep 28, 2018 09:27AM

15,414 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All